CLINICAL_TRIALS
trial_result
· 2020-08-25
Clinical Trial Update: Alimta Plus Gemcitabine for Advanced Sarcoma [Phase 2]
Summary
Phase 2 trial evaluating Alimta (pemetrexed) plus gemcitabine for advanced soft tissue sarcoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: COMPLETED | Results posted: 2020-08-25